BBP vs. AGNG
BBP (Virtus LifeSci Biotech Products ETF) and AGNG (Global X Aging Population ETF) are both Health & Biotech Equities funds - BBP tracks the LifeSci Biotechnology Products Index while AGNG tracks the Indxx Aging Population Thematic Index. Both are passively managed. Over the past 10 years, BBP returned 11.72%/yr vs 8.91%/yr for AGNG. A 0.60 correlation means they provide meaningful diversification when combined. BBP charges 0.79%/yr vs 0.50%/yr for AGNG.
Performance
BBP vs. AGNG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBP achieves a 8.38% return, which is significantly higher than AGNG's -2.82% return. Over the past 10 years, BBP has outperformed AGNG with an annualized return of 11.72%, while AGNG has yielded a comparatively lower 8.91% annualized return.
BBP
- 1D
- 2.44%
- 1M
- -0.92%
- YTD
- 8.38%
- 6M
- 9.14%
- 1Y
- 48.00%
- 3Y*
- 17.11%
- 5Y*
- 10.90%
- 10Y*
- 11.72%
AGNG
- 1D
- 2.07%
- 1M
- -0.03%
- YTD
- -2.82%
- 6M
- -3.18%
- 1Y
- 11.38%
- 3Y*
- 8.98%
- 5Y*
- 4.39%
- 10Y*
- 8.91%
BBP vs. AGNG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 8.38% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 24.73% | -13.95% | 24.07% |
AGNG Global X Aging Population ETF | -2.82% | 20.01% | 7.03% | 9.65% | -8.61% | 3.91% | 18.96% | 25.24% | -1.45% | 28.17% |
Correlation
The correlation between BBP and AGNG is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.63 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.61 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.66 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since May 11, 2016 | 0.60 |
The correlation between BBP and AGNG has been stable across timeframes, ranging from 0.60 to 0.66 - a consistent structural relationship.
BBP vs. AGNG - Sectors Allocation Comparison
Sectors
BBP
AGNG
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
Technology
-
-
Utilities
-
-
Healthcare
BBP
AGNG
Basic Materials
BBP
-
AGNG
-
Communication Services
BBP
-
AGNG
-
Consumer Cyclical
BBP
-
AGNG
-
Consumer Defensive
BBP
-
AGNG
-
Energy
BBP
-
AGNG
-
Financial Services
BBP
-
AGNG
-
Industrials
BBP
-
AGNG
-
Real Estate
BBP
-
AGNG
Technology
BBP
-
AGNG
-
Utilities
BBP
-
AGNG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBP vs. AGNG — Risk / Return Rank
BBP
AGNG
BBP vs. AGNG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Global X Aging Population ETF (AGNG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBP | AGNG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.19 | ||
| Sortino ratioReturn per unit of downside risk | +1.59 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.15 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 5.20 | 1.00 | +4.20 |
| Martin ratioReturn relative to average drawdown | 16.27 | 2.69 | +13.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBP | AGNG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.02 | 0.83 | +1.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.29 | +0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.52 | -0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.54 | -0.14 |
Drawdowns
BBP vs. AGNG - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, which is greater than AGNG's maximum drawdown of -30.58%. Use the drawdown chart below to compare losses from any high point for BBP and AGNG.
Loading charts...
Drawdown Indicators
| BBP | AGNG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -30.58% | -13.74% |
Max Drawdown (1Y)Largest decline over 1 year | -9.28% | -11.45% | +2.17% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -14.48% | -11.61% |
Max Drawdown (5Y)Largest decline over 5 years | -38.28% | -25.66% | -12.62% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | -30.58% | -13.74% |
Current DrawdownCurrent decline from peak | -4.18% | -9.25% | +5.07% |
Average DrawdownAverage peak-to-trough decline | -12.02% | -5.95% | -6.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.96% | 4.24% | -1.28% |
Volatility
BBP vs. AGNG - Volatility Comparison
Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 8.03% compared to Global X Aging Population ETF (AGNG) at 4.43%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than AGNG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBP | AGNG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.03% | 4.43% | +3.60% |
Volatility (6M)Calculated over the trailing 6-month period | 18.52% | 10.21% | +8.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.84% | 13.77% | +10.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.37% | 15.24% | +11.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.41% | 17.14% | +10.27% |
BBP vs. AGNG - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than AGNG's 0.50% expense ratio.
Dividends
BBP vs. AGNG - Dividend Comparison
BBP has not paid dividends to shareholders, while AGNG's dividend yield for the trailing twelve months is around 0.90%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGNG Global X Aging Population ETF | 0.90% | 0.88% | 0.83% | 0.96% | 0.49% | 0.72% | 0.36% | 0.83% | 1.00% | 1.04% | 0.45% | 0.00% |
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
Frequently Asked Questions
BBP and AGNG have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBP has higher volatility (8.03%) compared to AGNG (4.43%). In terms of maximum drawdown, BBP dropped -44.32% vs AGNG's -30.58%.
On 10-year performance, BBP leads with 11.72% vs 8.91% for AGNG. On fees, AGNG is cheaper at 0.50% per year. On volatility, AGNG has been the lower-risk option at 4.43%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BBP has performed better with a 11.72% return vs 8.91%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
AGNG is cheaper with a 0.50% expense ratio, compared with 0.79% for BBP.
AGNG has the higher dividend yield at 0.90%, compared with 0.00% for BBP.
BBP tracks LifeSci Biotechnology Products Index, while AGNG tracks Indxx Aging Population Thematic Index. They also come from different issuers: Virtus Investment Partners and Global X. Their fees differ too: 0.79% for BBP and 0.50% for AGNG.
BBP currently has the higher Sharpe Ratio (2.02 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBP and AGNG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer